| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.3033 | 52 |
| GSM780708 | Untreated after 4 days (C2_1) | 56.4364 | 61 |
| GSM780709 | Untreated after 4 days (C3_1) | 53.4398 | 57 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.5601 | 55 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.7425 | 53 |
| GSM780721 | Untreated after 4 days (C3_2) | 58.5208 | 63 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.634 | 57 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 51.7425 | 53 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.101 | 18 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 53.2021 | 57 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.2704 | 52 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 58.2056 | 63 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.9446 | 45 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.5912 | 43 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 56.1939 | 61 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 49.4801 | 47 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.1417 | 58 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.8404 | 40 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 53.8387 | 58 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.868 | 56 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 57.9836 | 63 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.1528 | 54 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.1179 | 56 |